Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.

Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ.

Sci Transl Med. 2011 Aug 17;3(96):96ra76. doi: 10.1126/scitranslmed.3002648.

3.

The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.

Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG.

Scand J Gastroenterol Suppl. 2001;(234):29-40. Review.

PMID:
11768558
4.

Novel drug delivery strategies for the treatment of inflammatory bowel disease.

Kesisoglou F, Zimmermann EM.

Expert Opin Drug Deliv. 2005 May;2(3):451-63. Review.

PMID:
16296767
5.

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

Hua S, Marks E, Schneider JJ, Keely S.

Nanomedicine. 2015 Jul;11(5):1117-32. doi: 10.1016/j.nano.2015.02.018. Epub 2015 Mar 14. Review.

6.

Vitamin D: new roles and therapeutic potential in inflammatory bowel disease.

Raftery T, O'Morain CA, O'Sullivan M.

Curr Drug Metab. 2012 Nov;13(9):1294-302. Review.

PMID:
22493989
7.

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.

Chengappa KN, Gershon S, Levine J.

Bipolar Disord. 2001 Oct;3(5):215-32. Review.

PMID:
11912568
8.

A pharmacological and clinical review on topiramate, a new antiepileptic drug.

Perucca E.

Pharmacol Res. 1997 Apr;35(4):241-56. Review.

PMID:
9264038
9.

Review of topiramate: an antiepileptic for the treatment of alcohol dependence.

Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM.

Curr Drug Abuse Rev. 2009 May;2(2):135-42. Review.

PMID:
19630744
10.

[Therapeutic drug monitoring of topiramate].

Bentué-Ferrer D, Tribut O, Verdier MC; le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.

Therapie. 2010 Jan-Feb;65(1):17-22. doi: 10.2515/therapie/2009066. Epub 2010 Mar 8. Review. French.

PMID:
20205990
11.

Spotlight on topiramate in epilepsy.

Lyseng-Williamson KA, Yang LP.

CNS Drugs. 2008;22(2):171-4. Review.

PMID:
18193927
12.

Topiramate: a new antiepileptic drug.

Markind JE.

Am J Health Syst Pharm. 1998 Mar 15;55(6):554-62. Review.

PMID:
9544331
13.

Medical therapy of inflammatory bowel disease for the 21st century.

Robinson M.

Eur J Surg Suppl. 1998;(582):90-8. Review.

PMID:
10029372
14.

Clinical pharmacology of topiramate in migraine prevention.

Ferrari A, Tiraferri I, Neri L, Sternieri E.

Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1169-81. doi: 10.1517/17425255.2011.602067. Epub 2011 Jul 15. Review.

PMID:
21756204
15.

Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.

Xiao B, Merlin D.

Expert Opin Drug Deliv. 2012 Nov;9(11):1393-407. doi: 10.1517/17425247.2012.730517. Epub 2012 Oct 5. Review.

PMID:
23036075
16.

The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review.

De Sousa A.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):45-9. Review.

PMID:
20201814
17.
18.

Review of the use of topiramate for treatment of bipolar disorders.

Suppes T.

J Clin Psychopharmacol. 2002 Dec;22(6):599-609. Review.

PMID:
12454560
19.

Topiramate add-on for drug-resistant partial epilepsy.

Pulman J, Jette N, Dykeman J, Hemming K, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2014 Feb 25;(2):CD001417. doi: 10.1002/14651858.CD001417.pub3. Review.

PMID:
24570033
20.

[Drug delivery strategies for targeted treatment of inflammatory bowel disease].

Lautenschläger C, Schmidt C, Lange K, Stallmach A.

Z Gastroenterol. 2015 Mar;53(3):226-34. doi: 10.1055/s-0034-1398793. Epub 2015 Feb 27. Review. German.

PMID:
25723326

Supplemental Content

Support Center